References
- Ferri CP , PrinceM , BrayneCet al. Global prevalence of dementia: a Delphi consensus study . Lancet366 ( 9503 ), 2112 – 2117 ( 2005 ).
- Budson AE , SolomonPR . New diagnostic criteria for Alzheimer’s disease and mild cognitive impairment for the practical neurologist . Pract. Neurol.12 ( 2 ), 88 – 96 ( 2013 ).
- Chouliaras L , MastroeniD , DelvauxEet al. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer’s disease patients . Neurobiol. Aging34 ( 9 ), 2091 – 2099 ( 2013 ).
- Iwata A , NagataK , HatsutaHet al. Altered CpG methylation in sporadic Alzheimer’s disease is associated with APP and MAPT dysregulation . Hum. Mol. Genet. doi: https://doi.org/10.1093/hmg/ddt451 ( 2013 ).
- Mastroeni D , GroverA , DelvauxE , WhitesideC , ColemanPD , RogersJ . Epigenetic changes in Alzheimer’s disease: decrements in DNA methylation . Neurobiol Aging31 ( 12 ), 2025 – 2037 ( 2010 ).
- Lunnon K , MillJ . Epigenetic studies in Alzheimer’s disease: Current findings, caveats, and considerations for future studies . Am. J. Med. Genet. B Neuropsychiatr. Genet. doi:10.1002/ajmg.b.322012013 ) ( Epub ahead of print ).
- Day JJ , SweattJD . Epigenetic mechanisms in cognition . Neuron70 ( 5 ), 813 – 829 ( 2011 ).
- Taher N , MckenzieC , GarrettR , BakerM , FoxN , IsaacsGD . Amyloid-beta alters the DNA methylation status of cell-fate genes in an Alzheimer’s disease model . J. Alzheimers Dis.38 ( 4 ), 831 – 844 ( 2013 ).
- Veerappan CS , SleimanS , CoppolaG . Epigenetics of Alzheimer’s disease and frontotemporal dementia . Neurotherapeutics10 ( 4 ), 709 – 721 ( 2013 ).
- Bradley-Whitman MA , LovellMA . Epigenetic changes in the progression of Alzheimer’s disease . Mech. Ageing Dev.134 ( 10 ), 486 – 495 ( 2013 ).
- Barnes DE , YaffeK , ByersAL , MccormickM , SchaeferC , WhitmerRA . Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia . Arch. Gen. Psychiatry69 ( 5 ), 493 – 498 ( 2012 ).
- Simic G , StanicG , MladinovM , Jovanov-MilosevicN , KostovicI , HofPR . Does Alzheimer’s disease begin in the brainstem?Neuropathol. Appl. Neurobiol.35 ( 6 ), 532 – 554 ( 2009 ).
- Rodriguez JJ , NoristaniHN , VerkhratskyA . The serotonergic system in ageing and Alzheimer’s disease . Prog. Neurobiol.99 ( 1 ), 15 – 41 ( 2012 ).
- Braak H , DelTredici K . The pathological process underlying Alzheimer’s disease in individuals under thirty . Acta Neuropathol.121 ( 2 ), 171 – 181 ( 2011 ).
- Davies MN , VoltaM , PidsleyRet al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood . Genome Biol.13 ( 6 ), R43 ( 2012 ).
- Adwan L , ZawiaNH . Epigenetics: a novel therapeutic approach for the treatment of Alzheimer’s disease . Pharmacol. Ther.139 ( 1 ), 41 – 50 ( 2013 ).
- Van Den Hove Dl , ChouliarasL , RuttenBP . The role of 5-hydroxymethylcytosine in aging and Alzheimer’s disease: current status and prospects for future studies . Curr. Alzheimer Res.9 ( 5 ), 545 – 549 ( 2012 ).
- Van Den Hove Dl , KompotisK , LardenoijeR , Epigenetically regulated microRNAs in Alzheimer’s disease . Neurobiol. Aging 35 ( 4 ), 731 – 745 ( 2013 ).